PPMD Community

Webinar: Ataluren (Translarna) Update with PTC

Event Details

Time: June 3, 2014 from 1pm to 2pm
Location: Eastern Time Zone
Website or Map: https://www.youtube.com/watch…
Event Type: webinar, ptc, translarna, ataluren
Organized By: PPMD
Latest Activity: Jun 16, 2014

Export to Outlook or iCal (.ics)

Favorite

0 members favorited this

Event Description

In a webinar hosted by United Parent Project Muscular Dystrophy, Robert Spiegel, MD, FACP, chief medical officer of PTC Therapeutics, presented an overview of the positive opinion by the Committee for Medicinal Products for Human Use of the European Medicines Agency regarding the company’s application for a conditional marketing authorization of Translarna^TM (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy, and what this decision means for families living in and outside the EU.

Comment Wall

Staff Comment by PPMD on June 16, 2014 at 9:41am: Hi Jennifer -- the link to the recording is now available: https://www.youtube.com/watch?v=H1DeTySZu0A